| Primary |
| Gastroenteritis |
40.0% |
| Asthma |
20.0% |
| Pneumonia Mycoplasmal |
20.0% |
| Vomiting |
20.0% |
|
| Anaphylactic Reaction |
50.0% |
| Asthma |
50.0% |
|
| Secondary |
| Analgesia |
11.0% |
| Pneumonia |
10.2% |
| Drug Use For Unknown Indication |
9.3% |
| Prophylaxis |
9.3% |
| Rheumatoid Arthritis |
9.3% |
| Peritonitis |
7.6% |
| Asthma |
5.9% |
| Pneumonia Staphylococcal |
5.1% |
| Sedation |
5.1% |
| Acute Myeloid Leukaemia Recurrent |
3.4% |
| Hypertension |
3.4% |
| Bronchitis |
2.5% |
| Diuretic Therapy |
2.5% |
| Hypotension |
2.5% |
| Septic Shock |
2.5% |
| Staphylococcal Infection |
2.5% |
| Tachycardia |
2.5% |
| Arteriosclerosis Obliterans |
1.7% |
| Diabetes Mellitus |
1.7% |
| Disseminated Intravascular Coagulation |
1.7% |
|
| Superinfection |
19.2% |
| Blood Bilirubin Increased |
11.5% |
| Hyperglycaemia |
11.5% |
| Blood Potassium Decreased |
7.7% |
| Spinal Compression Fracture |
7.7% |
| White Blood Cell Count Decreased |
7.7% |
| Amylase Increased |
3.8% |
| Anaphylactic Reaction |
3.8% |
| Blood Amylase Increased |
3.8% |
| Liver Disorder |
3.8% |
| Osteonecrosis |
3.8% |
| Tracheal Disorder |
3.8% |
| Tuberculous Pleurisy |
3.8% |
| Upper Respiratory Tract Inflammation |
3.8% |
| Ventricular Flutter |
3.8% |
|
| Concomitant |
| Prophylaxis |
34.3% |
| Product Used For Unknown Indication |
11.0% |
| Pain |
7.3% |
| Asthma |
7.0% |
| Drug Use For Unknown Indication |
6.4% |
| Neoplasm Malignant |
6.2% |
| Aplastic Anaemia |
3.6% |
| Premedication |
3.3% |
| Constipation |
2.6% |
| Stem Cell Transplant |
2.3% |
| Hypertension |
2.1% |
| Colon Cancer |
1.9% |
| Infection Prophylaxis |
1.9% |
| Rheumatoid Arthritis |
1.8% |
| Gastritis |
1.7% |
| Insomnia |
1.6% |
| Ovarian Cancer Recurrent |
1.4% |
| Bronchitis |
1.3% |
| Pneumonia |
1.2% |
| Pyrexia |
1.2% |
|
| White Blood Cell Count Decreased |
12.8% |
| Pyrexia |
9.5% |
| White Blood Cell Count Increased |
7.4% |
| Sepsis |
6.8% |
| Vomiting |
6.1% |
| Thrombocytopenia |
5.4% |
| Liver Disorder |
4.7% |
| T-cell Lymphoma |
4.7% |
| Anaphylactic Shock |
4.1% |
| Epistaxis |
4.1% |
| Pancytopenia |
4.1% |
| Thyroid Cancer |
4.1% |
| Ventricular Tachycardia |
4.1% |
| Vision Blurred |
4.1% |
| Death |
3.4% |
| Subarachnoid Haemorrhage |
3.4% |
| Toxic Epidermal Necrolysis |
3.4% |
| Feeling Abnormal |
2.7% |
| Platelet Count Decreased |
2.7% |
| Renal Failure Acute |
2.7% |
|
